supplementary figure b-1. bile acid biosynthesis pathway in metformin therapy group
DESCRIPTION
Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group. Supplementary Figure B-2. Ascorbate and aldarate metabolism pathway in Metformin therapy group. Supplementary Figure B-3. Hepatic Fibrosis-Hepatic Stellate cell activation pathway in Metformin therapy group. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/1.jpg)
Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group
![Page 2: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/2.jpg)
Supplementary Figure B-2. Ascorbate and aldarate metabolism pathway in Metformin therapy group
![Page 3: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/3.jpg)
Supplementary Figure B-3. Hepatic Fibrosis-Hepatic Stellate cell activation pathway in Metformin therapy group
![Page 4: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/4.jpg)
Supplementary Figure B-4. C21-Steroid Hormone Metabolism pathway in Metformin therapy group
![Page 5: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/5.jpg)
Supplementary Figure B-5. Androgen and Estrogen Metabolism pathway in Metformin therapy group
![Page 6: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/6.jpg)
Supplementary Figure B-6. Glycerolipid Metabolism pathway in Metformin therapy group
![Page 7: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/7.jpg)
Supplementary Figure B-7. LPS/IL1 Mediated Inhibition of RXR Function pathway in Metformin therapy group
![Page 8: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/8.jpg)
Supplementary Figure B-8. G-Protein Coupled Receptor Signaling pathway in Metformin therapy group
![Page 9: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/9.jpg)
Supplementary Figure B-9. Human Embryonic Stem cell Pluripotency pathway in Metformin therapy group
![Page 10: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/10.jpg)
Supplementary Figure B-10. FXR/RXR Activation pathway in Metformin therapy group
![Page 11: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/11.jpg)
Supplementary Figure B-11. Hereditary Breast Cancer Signaling pathway in Metformin therapy group
![Page 12: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/12.jpg)
Supplementary Figure B-12. Regulation of eIF4 and p70S6K Signaling pathway in Metformin therapy group
![Page 13: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/13.jpg)
Supplementary Figure B-13. EIF2 Signaling pathway in Metformin therapy group
![Page 14: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/14.jpg)
Supplementary Figure B-14. Pancreatic Adenocarcinoma Signaling pathway in Metformin therapy group
![Page 15: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/15.jpg)
Supplementary Figure B-15. Role of BRCA1 in DNA Damage Receptor pathway in Metformin therapy group
![Page 16: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/16.jpg)
Supplementary Figure B-16. p53 Signaling pathway in Metformin therapy group
![Page 17: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/17.jpg)
Supplementary Figure B-17. Ceramid Signaling pathway in Metformin therapy group
![Page 18: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/18.jpg)
Supplementary Figure B-18. mTOR Signaling pathway in Metformin therapy group
![Page 19: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/19.jpg)
Supplementary Figure B-19. Glucocorticoid Receptor Signaling pathway in Metformin therapy group
![Page 20: Supplementary Figure B-1. Bile acid biosynthesis pathway in Metformin therapy group](https://reader036.vdocument.in/reader036/viewer/2022062517/56813de0550346895da7af83/html5/thumbnails/20.jpg)
Supplementary Figure B-20. Role of CHK Proteins in Cell Cycle Checkpoint Control pathway in Metformin therapy group